Depression risk for patients receiving GLP-1 RA was slightly higher than those receiving SGLT-2i and lower than those receiving DPP-4i.

Patients who continued Ozempic through total joint arthroplasty had higher risk for complications compared with those who stopped GLP-1RAs before surgery.

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonist use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use.

Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that myriad variables are causing patients to stop treatment. When GLP-1 drugs ...

Lady Gaga is set to take on Chappell Roan for Number 1 this week – Abracadabra (2) is less than 1,400 chart units away from Pink Pony Club (1), which became the first UK chart-topper for pop ...

Jelly Roll Last week Weeks at no. 1 Weeks on chart J.B.DeFord, B.J.Johnson, A.G.Gorley, T.Phillips Z.Crowell Bailee & Buddy/BMG/Republic/Stoney Creek Gains In Performance Week of March 15 ...

over 6000 assets (including all Forex pairs, Cryptocurrencies, Commodities, Indices and US stocks) unique interbank rates extensive historic data the option to save your configuration Here below ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

2-Year U.S. Treasury Note Continuous Contract $103.523-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.898-0.055-0.05% 10-Year U.S. Treasury Note Continuous Contract $110.875-0.063 ...